Why is Boston Bio falling/rising?

As of 17-Sep, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.96, which reflects a decrease of 0.04 or 0.5%. The stock has underperformed its sector by 0.91% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 1.12% during this period. Additionally, while the stock's performance over the past month shows a slight increase of 0.76%, it has notably underperformed the benchmark Sensex, which has risen by 2.60% in the same timeframe. The stock's moving averages indicate that it is currently higher than the 50-day and 100-day averages but lower than the 5-day, 20-day, and 200-day averages. There is a positive note regarding rising investor participation, as the delivery volume increased by 35.78% against the 5-day average, suggesting some interest despite the price decline. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.
Broader Market Context: In the short term, Boston Bio's performance has been less favorable compared to the benchmark Sensex, which has gained 1.56% over the past week, while Boston Bio has seen a decline of 4.56%. This significant underperformance relative to the broader market may contribute to investor sentiment and the stock's recent price movement. The liquidity of the stock remains adequate, allowing for trades without significant issues, but the overall market context and the stock's recent consecutive falls suggest a challenging environment for Boston Bio Systems Ltd at this time.